Use of phosphodiesterase-5 inhibitors by college students

Rev Saude Publica. 2008 Oct;42(5):965-7. Epub 2008 Aug 21.
[Article in English, Portuguese]

Abstract

The objective of this study was to identify the use of phosphodiesterase type 5 inhibitors among university students from the city of Sao Paulo (SP) in Brazil. Male students (n=350) replied to a questionnaire about diagnosis of erectile dysfunction, the frequency and reason for the use of phosphodiesterase type 5 inhibitors, the specific medication used, whether their use was accompanied by a medical prescription and any reported side-effects. The results shows that a total of 53 (14.7%) students had already used this kind of medication without a prescription or medical diagnosis for erectile dysfunction, of which 53% reported using sildenafil, 37% tadalafil and 10% vardenafil. The main adverse side-effects reported were headache (23%) and flushing (10%) and the main reasons for using the inhibitor were curiosity (70%) and erectile improvement (12%).

MeSH terms

  • Adolescent
  • Adult
  • Brazil
  • Carbolines / therapeutic use
  • Erectile Dysfunction / drug therapy*
  • Humans
  • Imidazoles / therapeutic use
  • Male
  • Phosphodiesterase Inhibitors / adverse effects
  • Phosphodiesterase Inhibitors / therapeutic use*
  • Piperazines / therapeutic use
  • Purines / therapeutic use
  • Self Medication / psychology
  • Self Medication / statistics & numerical data*
  • Sildenafil Citrate
  • Students / psychology
  • Students / statistics & numerical data*
  • Sulfones / therapeutic use
  • Tadalafil
  • Triazines / therapeutic use
  • Vardenafil Dihydrochloride
  • Vasodilator Agents / adverse effects
  • Vasodilator Agents / therapeutic use*
  • Young Adult

Substances

  • Carbolines
  • Imidazoles
  • Phosphodiesterase Inhibitors
  • Piperazines
  • Purines
  • Sulfones
  • Triazines
  • Vasodilator Agents
  • Vardenafil Dihydrochloride
  • Tadalafil
  • Sildenafil Citrate